LoginRegister
    Abbvie finalizes deal to buy Botox maker Allergan for $63 billionAbbvie finalizes deal to buy Botox maker Allergan for $63 billion
    Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with CelgeneBristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene
    Opioid use booming as tramadol crisis emerges in Africa- UN drug reportOpioid use booming as tramadol crisis emerges in Africa- UN drug report
    More than 10 percent of Drug samples from Government sources Not of Standard QualityMore than 10 percent of Drug samples from Government sources Not of Standard Quality
    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsulesAlembic Pharma gets USFDA nod for generic version of Tamiflu capsules
    Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in TelanganaIndian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana
    Dr Reddys unveils generic version of Vitamin K1 injection in USDr Reddys unveils generic version of Vitamin K1 injection in US
    Lawsuit: Generic drug makers used code to fix price increasesLawsuit: Generic drug makers used code to fix price increases
    Oklahoma judge approves Teva Pharma USD 85 million opioid settlementOklahoma judge approves Teva Pharma USD 85 million opioid settlement
    Neuland Labs gets 5 USFDA observations for Bonthapally facilityNeuland Labs gets 5 USFDA observations for Bonthapally facility
    Novartis, Glenmark enter partnership to commercialize, distribute respiratory drugs Seebri, Onbrize, UltibroNovartis, Glenmark enter partnership to commercialize, distribute respiratory drugs Seebri, Onbrize,...
    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic SolutionAlembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X